Cytena secures €3M in funding to advance its single-cell technology
By Nikita Chaurasia  Date: 2019-03-27

Cytena secures €3M in funding to advance its single-cell technology
  • The capital will help to broaden the sales activities of Cytena and capitalize on new applications
  • Single-cells are used in the development of biopharmaceuticals and in stem cell and cancer research

Reports confirm that High-Tech Grunderfonds (HTGF) and two private investors are going to invest another 3 million euros in Cytena GmbH. This capital will be used in developing Cytena’s single-cell printer lab technology, broaden its sales activities and promptly tap into the capabilities of new applications.

Apparently, the two private investors and High-Tech Grunderfonds (HTGF) have confidence in the significance of isolation of single-cell for the development of biopharmaceuticals as well as for genetic analysis in diagnostics and research.

Benjamin Steimle, CFO of Cytena stated that the new capital would help to understand better and serve the customer’s requirements as well as help to increase the market share of the company.

Cytena mentioned that along with way, important milestones achieved include a collaboration in sales with a vital American company and addition of x.sight devices.

In recent years, the analysis of individual biological cells has gained its importance rapidly. These single-cells are used in the development of latest drugs called biopharmaceuticals and also in stem cell and cancer research, the firm said.

Cytena’s single cell printers comprise of laboratory devices for sorting and managing individual viable cells. These instruments are considered as one of the innovative platforms for life science and offer long-term contribution towards the manufacturing and development of new drugs.

According to HTGF Investment Manager, Dr. Lena Krzyzak, investment in the Series A round helps the company to continues its successful growth in start-up financing. Dr. Krzyzak said with the company is greatly confident in its management team’s ability to expand the market and product development.

For the uninitiated, Cytena is a well-known start-up in life sciences which was founded in 2014 at the University of Freiburg, by spinning off from the Institute for Microsystems Technology (IMTEK). The Cytena team has developed the technology called the single-cell printer which enables the isolation of single cells in a gentle, sterile and documented process.

About Author

Nikita Chaurasia    

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

Generac, Baker partner to offer solar & storage installations in U.S.
Generac, Baker partner to offer solar & storage installations in U.S.
By Nikita Chaurasia

Generac Holdings Inc., a Wisconsin-based leading backup power generation developer, has reportedly entered a joint venture agreement with a solar electric solutions provider Baker Electric Home Energy. Sources close to the matter stated that the two ...

Education analytics platform HelioCampus acquires ABC Insights
Education analytics platform HelioCampus acquires ABC Insights
By Nikita Chaurasia

HelioCampus, a leading higher education analytics platform that offers universities and colleges the decision-support assistance they require to work more sustainably and strategically, has reportedly announced that it acquired ABC Insights, a renown...

Deutsche Telekom, OVHcloud partner to offer cloud services in Europe
Deutsche Telekom, OVHcloud partner to offer cloud services in Europe
By Nikita Chaurasia

Deutsche Telekom AG, the German telecommunication services provider, has reportedly teamed up with a France-based company OVHcloud. Sources with knowledge of the matter stated that the two companies intend to provide alternative cloud computing servi...

Graphics firm NVIDIA to acquire Arm from SoftBank for $40 billion
Graphics firm NVIDIA to acquire Arm from SoftBank for $40 billion
By Nikita Chaurasia

NVIDIA, a leading American multinational technology firm, and SoftBank, a renowned Japanese conglomerate, have reportedly announced that NVIDIA would acquire Arm Limited from SoftBank Group for a total amount of $40 billion. The agreement would be im...

QHR Health buys Resolution to reinforce its community health services
QHR Health buys Resolution to reinforce its community health services
By Nikita Chaurasia

In a recent turn of events, U.S.-based technological healthcare company QHR Health has reportedly announced the acquisition of revenue cycle services provider, Resolution, in order to strengthen its community healthcare services across the United Sta...